Similar articles

• [Clinical evaluation of rifampicin for pulmonary tuberculosis. 3. A controlled trial on the clinical effects of chemotherapy with rifampicin-ethambutol and viomycin-ethambutol in retreatment cases of pulmonary tuberculosis].

  Donomae I, Fujita S, Gomi J, Hibino S, Horai Z. Donomae I, et al. Kekkaku. 1971 Sep;46(9):371-7. Kekkaku. 1971. PMID: 4330662 Clinical Trial. Japanese. No abstract available.
• A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council Investigation.

  [No authors listed] [No authors listed] Tubercle. 1974 Mar;55(1):1-27. Tubercle. 1974. PMID: 4620294 Clinical Trial. No abstract available.
• Rifampicin with ethambutol for drug-resistant tuberculosis.

  Pines A. Pines A. Br J Dis Chest. 1971 Jul;65:178-81. doi: 10.1016/0007-0971(71)90021-0. Br J Dis Chest. 1971. PMID: 4997816 No abstract available.
• [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].

  Masztalerz J. Masztalerz J. Pneumonol Pol. 1976;44(1):55-60. Pneumonol Pol. 1976. PMID: 821043 Polish. No abstract available.
• [Drug therapy of tuberculosis in the child].

  Freerksen E. Freerksen E. Monatsschr Kinderheilkd (1902). 1969 Aug;117(8):513-8. Monatsschr Kinderheilkd (1902). 1969. PMID: 4921462 Review. German. No abstract available.